The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide-based drugs, Ozempic and Wegovy – since 2022 amid unprecedented demand.
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Related Posts
-
Brent Hinson named Ankeny’s new assistant city manager
Brent Hinson, Mason City’s deputy city administrator since 2021, will join Ankeny as assistant city…
-
Minnesota county probing viral ICE arrest of U.S. citizen
A viral photo showed ICE agents removing a U.S. citizen from his home in freezing…
-
Man accused in Molotov cocktail attack of OpenAI CEO’s home charged with attempted murder
The man accused of throwing a Molotov cocktail at OpenAI CEO Sam Altman’s home in…
-
Judge to decide on bond reduction for Kristin Ramsey in Okland murder case
Kristin Ramsey, charged with first-degree murder in the 2011 death of Ashley Okland, awaits a…
Leave a Reply